Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study

Christian Torgersen, Christian A Schmittinger, Sarah Wagner, Hanno Ulmer, Jukka Takala, Stephan M Jakob, Martin W Dünser, Christian Torgersen, Christian A Schmittinger, Sarah Wagner, Hanno Ulmer, Jukka Takala, Stephan M Jakob, Martin W Dünser

Abstract

Introduction: Despite the key role of hemodynamic goals, there are few data addressing the question as to which hemodynamic variables are associated with outcome or should be targeted in cardiogenic shock patients. The aim of this study was to investigate the association between hemodynamic variables and cardiogenic shock mortality.

Methods: Medical records and the patient data management system of a multidisciplinary intensive care unit (ICU) were reviewed for patients admitted because of cardiogenic shock. In all patients, the hourly variable time integral of hemodynamic variables during the first 24 hours after ICU admission was calculated. If hemodynamic variables were associated with 28-day mortality, the hourly variable time integral of drops below clinically relevant threshold levels was computed. Regression models and receiver operator characteristic analyses were calculated. All statistical models were adjusted for age, admission year, mean catecholamine doses and the Simplified Acute Physiology Score II (excluding hemodynamic counts) in order to account for the influence of age, changes in therapies during the observation period, the severity of cardiovascular failure and the severity of the underlying disease on 28-day mortality.

Results: One-hundred and nineteen patients were included. Cardiac index (CI) (P = 0.01) and cardiac power index (CPI) (P = 0.03) were the only hemodynamic variables separately associated with mortality. The hourly time integral of CI drops <3, 2.75 (both P = 0.02) and 2.5 (P = 0.03) L/min/m2 was associated with death but not that of CI drops <2 L/min/m2 or lower thresholds (all P > 0.05). The hourly time integral of CPI drops <0.5-0.8 W/m2 (all P = 0.04) was associated with 28-day mortality but not that of CPI drops <0.4 W/m2 or lower thresholds (all P > 0.05).

Conclusions: During the first 24 hours after intensive care unit admission, CI and CPI are the most important hemodynamic variables separately associated with 28-day mortality in patients with cardiogenic shock. A CI of 3 L/min/m2 and a CPI of 0.8 W/m2 were most predictive of 28-day mortality. Since our results must be considered hypothesis-generating, randomized controlled trials are required to evaluate whether targeting these levels as early resuscitation endpoints can improve mortality in cardiogenic shock.

Figures

Figure 1
Figure 1
Schematic description of the cardiac index time integral and the time integral of cardiac index drops below 3 L/min/m2 during the first 24 hours after intensive care unit admission. Dotted area = cardiac index time integral. Coloured area = time integral of cardiac index drops below 3 L/min/m2.
Figure 2
Figure 2
Histograms showing the time in hours of hemodynamic variable recordings in the study population. CVP = central venous pressure; HR = heart rate; MAP = mean arterial blood pressure; PAC = pulmonary artery catheter.

References

    1. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36(1 Suppl):S106–111. doi: 10.1097/01.CCM.0000296273.72952.39.
    1. El Mokhtari NE, Arlt A, Meissner A, Lins M. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. Eur J Med Res. 2008;13:459–463.
    1. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier HD, Ocampo HA. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest. 1989;96:120–126. doi: 10.1378/chest.96.1.120.
    1. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293–316. doi: 10.1177/0885066609340519.
    1. Varga A, Garcia MA, Picano E. International Stress Echo Complication Registry. Safety of stress echocardiography. Am J Cardiol. 2006;98:541–543. doi: 10.1016/j.amjcard.2006.02.064.
    1. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–548. doi: 10.1056/NEJMoa043046.
    1. Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol. 2009;53:1320–1325. doi: 10.1016/j.jacc.2009.02.020.
    1. Silberbauer J, Hong P, Lloyd GW. Takotsubo cardiomyopathy (left ventricular apical abllooning syndrome) induced during dobutamine stress echocardiography. Eur J Echocardiogr. 2008;9:136–138.
    1. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol. 2004;89:407–416. doi: 10.1113/expphysiol.2004.027482.
    1. Culling W, Penny WJ. Arrhythmogenic and electrophysiological effects of alpha adrenoreceptor stimulation during myocardial ischemia and reperfusion. J Mol Cell Cardiol. 1987;19:251–258. doi: 10.1016/S0022-2828(87)80592-8.
    1. Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes. Circulation. 2008;117:686–697. doi: 10.1161/CIRCULATIONAHA.106.613596.
    1. Mäkivirta A, Koski E, Kari A, Sukuvaara T. The median filter as a preprocessor for a patient monitor limit alarm system in intensive care. Comput Methods Programs Biomed. 1991;34:139–144. doi: 10.1016/0169-2607(91)90039-V.
    1. Takala J, Dellinger RP, Koskinen K, St Andre A, Read M, Levy M, Jakob SM, Mello PV, Friolet R, Ruokonen E. CPIC Study Group. Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study. Intensive Care Med. 2008;34:1401–1410. doi: 10.1007/s00134-008-1084-x.
    1. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963. doi: 10.1001/jama.270.24.2957.
    1. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710. doi: 10.1007/BF01709751.
    1. Jakob SM, Korhonen I, Ruokonen E, Virtanen T, Kogan A, Takala J. Detection of artifacts in monitored trends in intensive care. Comput Methods Programs Biomed. 2000;63:203–209. doi: 10.1016/S0169-2607(00)00110-3.
    1. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol. 2003;18:215–222. doi: 10.1097/00001573-200305000-00007.
    1. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–634. doi: 10.1056/NEJM199908263410901.
    1. Faxon DP. Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing. Nat Clin Pract Cardiovasc Med. 2005;2:22–28. doi: 10.1038/ncpcardio0065.
    1. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44:340–348. doi: 10.1016/j.jacc.2004.03.060.
    1. Hasdai D, Holmes DR, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am Heart J. 1999;138:21–31. doi: 10.1016/S0002-8703(99)70241-3.
    1. Tan LB, Littler WA. Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management. Br Heart J. 1990;64:121–128. doi: 10.1136/hrt.64.2.121.
    1. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized trial. Intensive Care Med. 1997;23:282–287. doi: 10.1007/s001340050329.
    1. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025–1032. doi: 10.1056/NEJM199510193331601.
    1. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717–1722. doi: 10.1056/NEJM199406163302404.
    1. Luchette FA, Jenkins WA, Friend LA, Su C, Fischer JE, James JH. Hypoxia is not the sole cause of lactate production during shock. J Trauma. 2002;52:415–419. doi: 10.1097/00005373-200203000-00001.
    1. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005;365:871–875. doi: 10.1016/S0140-6736(05)71045-X.
    1. Müller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care. 2008;12:R20. doi: 10.1186/cc6794.
    1. Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M. Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous? Dtsch Med Wochenschr. 2004;129:1925–1930. doi: 10.1055/s-2004-831364.

Source: PubMed

3
Subscribe